What is the current Blood Transfusion Devices market size?

The current Blood Transfusion Devices market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Blood Transfusion Devices market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Blood Transfusion Devices market?

Key drivers include rising patient populations, advancements in technology, and growing awareness of transfusion safety.

What are the major challenges facing the Blood Transfusion Devices market?

Challenges include high costs, regulatory hurdles, and risks of transfusion-transmitted infections.

Which regions are expected to lead the Blood Transfusion Devices market?

North America and Europe are expected to dominate, due to well-established healthcare systems.

Who are the top companies in the Blood Transfusion Devices market?

Top companies include Medtronic, Fresenius, and Haemonetics, offering innovative products and services.

What are the future opportunities in the Blood Transfusion Devices market?

Future opportunities include emerging markets, advancements in transfusion technology, and growing demand for blood components.

How is technology impacting the Blood Transfusion Devices market?

Technology is improving device safety, efficiency, and patient outcomes, with advancements in automation and digitalization.

What is the current regulatory landscape for the Blood Transfusion Devices market?

The regulatory landscape is evolving, with stricter guidelines and standards for device safety, efficacy, and quality.

What is the future outlook for the Blood Transfusion Devices market?

The future outlook is positive, with growing demand, innovative products, and increasing adoption of transfusion devices.

Global Blood Transfusion Devices Market Value Is Forecast To Reach By 2034 With CAGR

Blood Transfusion Devices by Application (Blood Collection, Blood Processing, Blood Safety, Other), by Types (Blood Collection, Blood Processing, Blood Safety, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $88 million

CAGR: 3.4%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $88 million

CAGR: 3.4%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Blood Transfusion Devices Market Size | CAGR 3.4% Forecast 2033

Global Blood Transfusion Devices Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $88 million

CAGR: 3.4%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $88 million

CAGR: 3.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Blood Transfusion Devices Market Overview

The Blood Transfusion Devices market refers to the industry that provides medical devices used for the transfer of blood or blood components from a donor to a recipient. The Blood Transfusion Devices market size is estimated to be approximately $4.5 billion in 2025. As the healthcare industry continues to evolve, the growth outlook for the Blood Transfusion Devices market is expected to be positive, driven by an increasing demand for safe and efficient blood transfusion procedures. The market forecast suggests that the industry will experience a compound annual growth rate (CAGR) of around 5-6% during the forecast period of 2026-2033, resulting in significant industry expansion. Key synonyms for this market include blood transfusion equipment, blood banking devices, and transfusion medicine devices.

Loading chart…

The growth of the Blood Transfusion Devices market is driven by several key forces, including technology shifts towards more advanced and automated devices, regulatory requirements for improved safety and efficiency, and changes in consumer behavior towards more personalized and patient-centric care. The largest region for the Blood Transfusion Devices market is currently North America, while the fastest-growing region is expected to be the Asia-Pacific region. Overall, the Blood Transfusion Devices market is expected to experience significant growth and industry expansion over the next few years, driven by increasing demand for safe and efficient blood transfusion procedures.

Report Overview

Report Attribute	Details
Market size value in 2025	88.00 million
Revenue forecast in 2033	153.48 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Macopharma; Becton Dickinson; B. Braun; Terumo; Abbott; Haemonetics; Fresenius Kabi; Immucor; Fenwal; Qmed; Cerus; Chindex Medical Limited; Armstrong Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Blood Transfusion Devices market is poised for significant growth, driven by various factors. The market dynamics are shaped by a combination of growth drivers, restraints, opportunities, and challenges that impact the Blood Transfusion Devices market size and growth forecast.

Growth Drivers2 items

Advances in technology, such as the development of automated blood transfusion systems, are enhancing the efficiency and safety of blood transfusions, driving the adoption of Blood Transfusion Devices.

Increasing demand for blood transfusions due to the rising prevalence of diseases that require blood transfusions, such as cancer and anemia, is fueling the growth of the Blood Transfusion Devices market.

Restraints2 items

Stringent regulatory requirements and high costs associated with the development and implementation of Blood Transfusion Devices are limiting the market growth.

Risk of transfusion-related complications, such as transfusion-related acute lung injury (TRALI), is a major concern, hindering the adoption of Blood Transfusion Devices.

Opportunities2 items

Emerging economies, such as Asia Pacific and Latin America, offer significant opportunities for the Blood Transfusion Devices market due to the increasing demand for blood transfusions and growing healthcare infrastructure.

The development of innovative Blood Transfusion Devices, such as point-of-care diagnostic devices, is expected to create new opportunities for market players.

Challenges2 items

Maintaining the quality and safety of blood transfusions is a major challenge, requiring significant investments in Blood Transfusion Devices and infrastructure.

The Blood Transfusion Devices market is highly competitive, with several established players, making it challenging for new entrants to gain market share and achieve a favorable growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Blood Transfusion Devices market refers to the various uses of these devices in medical settings. This includes blood banks, hospitals, and clinical research institutions. Blood Transfusion Devices segmentation is a critical aspect of understanding the market, as different applications have distinct requirements and preferences. The application segment contributes significantly to the overall Blood Transfusion Devices market size, with blood banks being the largest contributor due to the high demand for blood transfusion devices in these settings.

The Types segment of the Blood Transfusion Devices market encompasses various subtypes, including [object Object] and [object Object]. These subtypes cater to specific needs within the blood transfusion process, such as blood collection, blood component separation, and blood storage. The types segment is crucial in the Blood Transfusion Devices market taxonomy, as it helps manufacturers and suppliers understand the demand for specific devices and develop targeted products. Understanding the types segment is essential for market players to navigate the complex landscape of Blood Transfusion Devices segmentation and capitalize on emerging trends and opportunities.

Blood Transfusion Devices Segmentation Breakdown10 items

Application

Blood Collection

Blood Processing

Blood Safety

Other

Types

Blood Collection

Blood Processing

Blood Safety

Other

Regional Insights

Loading chart…

The Blood Transfusion Devices market growth is expected to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The Asia Pacific region is anticipated to be the fastest-growing, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers comprise stringent policies, a strong ecosystem, and significant investments in research and development. The Asia Pacific region is driven by rapid adoption, increasing investments, and growing demographics. Latin America and Middle East & Africa are driven by improving infrastructure, increasing adoption, and favorable policies, although at a slower pace.

The regional forecast indicates a shift towards the Asia Pacific region, driven by its large and growing population, increasing demand for blood transfusion devices, and rising investments in healthcare. As the Blood Transfusion Devices market growth continues, understanding regional dynamics will be crucial for stakeholders to capitalize on emerging opportunities and navigate challenges.

Competitive Landscape

The Blood Transfusion Devices market is moderately consolidated, with a mix of global players and local companies competing for market share. The Blood Transfusion Devices competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on expanding their product portfolios and strengthening their distribution networks, while local companies are concentrating on providing customized solutions and building strong relationships with regional healthcare providers.

Companies in the Blood Transfusion Devices market are adopting various strategies to differentiate themselves and gain a competitive edge. These strategies include mergers and acquisitions, partnerships, product launches, expansion, research and development, and localization. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can erode their profitability and make it difficult to sustain their market position. To overcome these challenges, companies are focusing on developing innovative products, strengthening their service models, and building strong channel relationships.

Macopharma: regional expansion

Becton Dickinson: premium pricing

B. Braun: innovation pipeline

Terumo: local manufacturing

Abbott: OEM tie-ups

Haemonetics: vertical integration

Key Blood Transfusion Devices Companies13 items

Macopharma

Becton Dickinson

B. Braun

Terumo

Abbott

Haemonetics

Fresenius Kabi

Immucor

Fenwal

Qmed

Cerus

Chindex Medical Limited

Armstrong Medical

Market Ecosystem

The Blood Transfusion Devices ecosystem encompasses a complex network of upstream, midstream, and downstream participants, including technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of blood transfusion devices, as well as the provision of related services. The ecosystem boundaries are defined by the interactions between these participants, from the supply of raw materials and components to the delivery of final products to end users.

Raw material suppliers — providing essential components

OEMs / manufacturers — designing and producing devices

Technology providers — developing underlying technologies

System integrators / EPCs — integrating devices into systems

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering maintenance and support

Regulators/standards bodies — establishing guidelines and approvals

In the Blood Transfusion Devices ecosystem, control points are influenced by regulators and standards bodies, who establish guidelines and approvals that impact adoption. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can vary by region. Switching costs and partnerships are also significant, as end users may be locked into specific devices or systems, and interoperability requirements can limit flexibility. A thorough value chain analysis is necessary to understand these dynamics and how they differ by region, ultimately shaping the overall ecosystem.

Recent Industry Insights

The Blood Transfusion Devices industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading medical device manufacturers and research institutions, have focused on enhancing the safety and efficiency of blood transfusion procedures. Furthermore, the industry has seen notable mergers and acquisitions, with companies aiming to expand their product portfolios and strengthen their market presence.

Additionally, several product and technology launches have taken place, introducing innovative solutions such as automated blood transfusion systems and advanced blood screening devices. Regulatory changes, including updated guidelines for blood transfusion practices, have also impacted the industry. A shift in consumer and enterprise trends towards more personalized and patient-centric care has driven the demand for advanced blood transfusion devices, with companies investing in funding rounds and expansions to meet this growing need.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Blood Transfusion Devices market outlook. The market attractiveness is moderate to high, driven by increasing demand for safe and efficient blood transfusion processes. The competitive intensity is high, with major players investing in innovative technologies to gain a competitive edge. The long-term outlook is positive, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with a focus on automated and portable devices. The demand-supply balance is currently stable, but may shift in the future due to changes in regulatory requirements. Key risk factors include stringent regulations and high development costs. Overall, the Blood Transfusion Devices market outlook is promising, with opportunities for growth and innovation.

11 items

1. Executive Summary

2. Blood Transfusion Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Transfusion Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Blood Transfusion Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Blood Collection

6.1.2. Blood Processing

6.1.3. Blood Safety

6.1.4. Other

6.2. Global Blood Transfusion Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Blood Collection

6.2.2. Blood Processing

6.2.3. Blood Safety

6.2.4. Other

6.3. Global Blood Transfusion Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Blood Transfusion Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Transfusion Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Blood Transfusion Devices Market Competition by Key Manufacturers

8.1. Global Blood Transfusion Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Blood Transfusion Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Macopharma

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Becton Dickinson

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. B. Braun

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Terumo

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Abbott

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Haemonetics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Fresenius Kabi

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Immucor

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Fenwal

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Qmed

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Cerus

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Chindex Medical Limited

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Armstrong Medical

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Transfusion Devices Market

Figure 4: Global Blood Transfusion Devices Market: Drivers

Figure 5: Global Blood Transfusion Devices Market: Challenges

Figure 6: Global Blood Transfusion Devices Market: Trends

Figure 7: Global Blood Transfusion Devices Market: Opportunity

Figure 8: Global Blood Transfusion Devices Market: Restraint

Figure 9: Global Blood Transfusion Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Blood Transfusion Devices Market Value (USD Million) By Region

Figure 15: Global Blood Transfusion Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Blood Transfusion Devices Market Value (USD Million) By Region

Figure 23: Global Blood Transfusion Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Transfusion Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Blood Transfusion Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Blood Transfusion Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Blood Transfusion Devices Market Value (USD Million) By Region

Table 10: Global Blood Transfusion Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Blood Transfusion Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Blood Transfusion Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Blood Transfusion Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Macopharma Basic Information And Sales Area

Table 31: Macopharma. Products Portfolio

Table 32: Becton Dickinson Basic Information And Sales Area

Table 33: Becton Dickinson. Products Portfolio

Table 34: B. Braun Basic Information And Sales Area

Table 35: B. Braun. Products Portfolio

Table 36: Terumo Basic Information And Sales Area

Table 37: Terumo. Products Portfolio

Table 38: Abbott Basic Information And Sales Area

Table 39: Abbott. Products Portfolio

Table 40: Haemonetics Basic Information And Sales Area

Table 41: Haemonetics. Products Portfolio

Table 42: Fresenius Kabi Basic Information And Sales Area

Table 43: Fresenius Kabi. Products Portfolio

Table 44: Immucor Basic Information And Sales Area

Table 45: Immucor. Products Portfolio

Table 46: Fenwal Basic Information And Sales Area

Table 47: Fenwal. Products Portfolio

Table 48: Qmed Basic Information And Sales Area

Table 49: Qmed. Products Portfolio

Table 50: Cerus Basic Information And Sales Area

Table 51: Cerus. Products Portfolio

Table 52: Chindex Medical Limited Basic Information And Sales Area

Table 53: Chindex Medical Limited. Products Portfolio

Table 54: Armstrong Medical Basic Information And Sales Area

Table 55: Armstrong Medical. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Blood Transfusion Devices Market Value (USD Million) By Region

Table 61: Global Blood Transfusion Devices Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Blood Transfusion Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	88.00 million
Revenue forecast in 2033	153.48 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Macopharma; Becton Dickinson; B. Braun; Terumo; Abbott; Haemonetics; Fresenius Kabi; Immucor; Fenwal; Qmed; Cerus; Chindex Medical Limited; Armstrong Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options